Though scientists have already identified the lower posterior of the rectum as significant for rectal toxicities after ...
A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...
The Brighterside of News on MSN
New drug combination stops prostate cancer growth in phase 3 clinical trial
An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...
The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...
News-Medical.Net on MSN
New drug combination could delay the progression of advanced prostate cancer
A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...
By Stephen Beech Men with advanced prostate cancer have been offered fresh hope thanks to a "promising" new drug combination.
In the discussion, Petrylak highlighted advances in identifying genetic mutations and emerging strategies for early, ...
Please provide your email address to receive an email when new articles are posted on . Black men with prostate cancer had significantly greater odds of having alterations in immunotherapy targets ...
News-Medical.Net on MSN
Unlocking the mysteries of treatment-resistant prostate cancer
Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease.
Men at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practice, whilst those at lowest risk could safely avoid invasive ...
Imagine a future where the moment you’re born, a virtual avatar is created and steadily filled with personalised information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results